4th Quarter - Termination

INVITROGEN CORPORATION for INVITROGEN CORPORATION

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Dec 31, 2008

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Financial Institutions/Investments/Securities FIN

HR1424: EMERGENCY ECONOMIC STABILIZATION ACT OF 2008; CREDIT MARKET STABILITY

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1424 (110th)

Copyright/Patent/Trademark CPT

S3600: PATENT REFORM ACT OF 2008; DAMAGES, RESEARCH USE EXCEPTION AND PATENT AND TRADEMARK OFFICE REFORM S1145: PATENT REFORM ACT OF 2007; DAMAGES, RESEARCH USE EXCEPTION AND PATENT AND TRADEMARK OFFICE REFORM

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

HR6498/S976: GENOMICS AND PERSONALIZED MEDICINE ACT; ALL ASPECTS OF BILL S3408: COMPARATIVE EFFECTIVENESS RESEARCH ACT OF 2008; ALL ASPECTS OF BILL

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6498 (110th)

Budget/Appropriations BUD

S3230: DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS ACT, 2009; NATIONAL INSTITUTES OF HEALTH & BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY FUNDING

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.